Etonoges vagin ring 3S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTLM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,082
Award facts
- Contract value 100% obligated
- $3,082.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,082.24 firm fixed-price delivery order (4570450013) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on January 9, 2026, with an ultimate completion date of January 12, 2026. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supporting Department of Defense pharmaceutical supply needs globally.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to federal military healthcare facilities, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and surgical products such as oncology treatments, immunosuppressants, emergency medications, and routine therapeutics. The company's underlying Indefinite Delivery Contract (SPE2DR) was awarded on November 13, 2025, with a ceiling value of $499,999,999 and an ultimate completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. As a critical supplier within the federal pharmaceutical supply chain since its System for Award Management registration in July 2001, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and consistent performance across multiple therapeutic categories and product lines to support military medical operations.
Quick answers
Who was awarded contract SPE2DR26FBTLM?
SPE2DR26FBTLM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FBTLM worth?
The government has obligated $3,082 on SPE2DR26FBTLM.
Is contract SPE2DR26FBTLM an order under another contract?
Yes. SPE2DR26FBTLM is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTLM competed?
The extent of competition for SPE2DR26FBTLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award